Box 1.
Signs and symptoms (proportion of patients affected) |
Obesity (38%) |
Menstrual disturbance (66%) |
Oligomenorrhea (47%) |
Amenorrhea (19%) |
[Regular cycle 30%] |
Hyperandrogenism (48%) |
Infertility (73% of anovulatory infertility) |
Symptomless–20% of those with polycystic ovaries |
Hormone systems that might be disturbed |
Insulin ↑ |
Sex-hormone-binding globulin ↓ |
Androgens (testosterone and androstenedione) ↑ |
Luteinizing hormone ↑ |
Prolactin ↑ |
Possible late sequelae |
Dyslipidemia |
Low-density lipoprotein (LDL) ↑, High-density lipoprotein (HDL) ↓ |
Triglycerides ↑ |
Diabetes mellitus |
Cardiovascular disease; hypertension |
Endometrial carcinoma |
Data from Balen A. Pathogenesis of polycystic ovary syndrome—the enigma unravels? Lancet 999;354:966.